Howard Colman

Howard Colman

UNVERIFIED PROFILE

Are you Howard Colman?   Register this Author

Register author
Howard Colman

Howard Colman

Publications by authors named "Howard Colman"

Are you Howard Colman?   Register this Author

91Publications

2985Reads

32Profile Views

A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma.

Authors:
Howard Colman

Neuro Oncol 2019 01;21(1):6-7

Huntsman Cancer Institute and Department of Neurosurgery, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noy190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303428PMC
January 2019

VHA Practice Guideline Recommendations for Diffuse Gliomas.

Fed Pract 2018 Aug;35(Suppl 5):S28-S35

is the Acting Chief of Pathology and Laboratory Medicine Service at VA Pittsburgh Healthcare System and member of the Division of Neuropathology at University of Pittsburgh Department of Pathology, is an Otolaryngologist at VA Pittsburgh Healthcare System, and is the Section Chief of Hematology\Oncology at VA Pittsburgh Healthcare System in Pennsylvania. is an Oncologist at VA-New York Harbor Healthcare System. is a Pathologist at University of Pittsburgh Department of Pathology in Pennsylvania. is Chief of Pathology and Laboratory Medicine Services at the South Texas Veterans Healthcare System in San Antonio. is the former Chief of Pathology and Laboratory Medicine Service at VA Pittsburgh Healthcare System. is a Pathologist at St. Louis VA Medical Center in Missouri. is the VA National Director of Pathology and Laboratory Medicine Services. is a Pathologist at Bay Pine Health Care System in Florida. is an Investigator at VA Salt Lake Health Care System Informatics and Computing Infrastructure. is an Oncologist at VA Puget Sound Health Care System, in Seattle, Washington. is the Director of Genomic Medicine Implementation and Associate Director of Genomic Medicine for the VA. is a Neuro-Oncologist at George E. Wahlen VA Medical Center and the Director of Medical Neuro-Oncology at the Huntsman Cancer Institute, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248149PMC
August 2018

Introduction. Update on adult neuro-oncology.

Neurosurg Focus 2018 06;44(6):E1

3Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2018.3.FOCUS18149DOI Listing
June 2018

Editorial. Potential survival benefit of resection in butterfly glioblastoma.

Authors:
Howard Colman

Neurosurg Focus 2018 06;44(6):E5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2018.3.FOCUS18152DOI Listing
June 2018

Mutant IDH1 Promotes Glioma Formation In Vivo.

Cell Rep 2018 05;23(5):1553-1564

Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.03.133DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032974PMC
May 2018

Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet?

Am Soc Clin Oncol Educ Book 2018 May;38:158-167

From the Massachusetts General Hospital, Harvard Medical School, Boston, MA; Departments of Neurosurgery, Neurology, and Internal Medicine (Oncology), Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Department of Neurology, The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, Netherlands; Division of Neuro-Oncology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_199247DOI Listing
May 2018

Toward more informative biomarker-based clinical trials in glioblastoma.

Authors:
Howard Colman

Neuro Oncol 2017 07;19(7):880-881

Department of Neurosurgery and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570242PMC
July 2017

Glioma Subclassifications and Their Clinical Significance.

Neurotherapeutics 2017 04;14(2):284-297

Department of Neurosurgery, Huntsman Cancer Institute and Clinical Neuroscience Center, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-017-0519-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398991PMC
April 2017

A 30-Year-Old Man with Three Primary Malignancies: A Case of Constitutional Mismatch Repair Deficiency.

ACG Case Rep J 2017 1;4:e34. Epub 2017 Mar 1.

Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Division of Gastroenterology and Hepatology, University of Utah, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14309/crj.2017.34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340720PMC
March 2017

Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.

J Neurooncol 2017 02 16;131(3):507-516. Epub 2017 Feb 16.

Department of Neurology, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2241-7DOI Listing
February 2017

New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.

Curr Neurol Neurosci Rep 2017 02;17(2):19

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-017-0722-5DOI Listing
February 2017

IGFBP2 expression predicts IDH-mutant glioma patient survival.

Oncotarget 2017 Jan;8(1):191-202

Department of Neurosurgery, Clinical Neurosciences Center, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352106PMC
January 2017

Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.

Curr Treat Options Oncol 2016 08;17(8):42

Department of Neurosurgery, Huntsman Cancer Institute and Clinical Neuroscience Center, University of Utah, 175 N. Medical Drive East, Salt Lake City, UT, 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-016-0418-0DOI Listing
August 2016

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis.

Authors:
Vijay Ramaswamy Thomas Hielscher Stephen C Mack Alvaro Lassaletta Tong Lin Kristian W Pajtler David T W Jones Betty Luu Florence M G Cavalli Kenneth Aldape Marc Remke Martin Mynarek Stefan Rutkowski Sridharan Gururangan Roger E McLendon Eric S Lipp Christopher Dunham Juliette Hukin David D Eisenstat Dorcas Fulton Frank K H van Landeghem Mariarita Santi Marie-Lise C van Veelen Erwin G Van Meir Satoru Osuka Xing Fan Karin M Muraszko Daniela P C Tirapelli Sueli M Oba-Shinjo Suely K N Marie Carlos G Carlotti Ji Yeoun Lee Amulya A Nageswara Rao Caterina Giannini Claudia C Faria Sofia Nunes Jaume Mora Ronald L Hamilton Peter Hauser Nada Jabado Kevin Petrecca Shin Jung Luca Massimi Massimo Zollo Giuseppe Cinalli László Bognár Almos Klekner Tibor Hortobágyi Sarah Leary Ralph P Ermoian James M Olson Jeffrey R Leonard Corrine Gardner Wieslawa A Grajkowska Lola B Chambless Jason Cain Charles G Eberhart Sama Ahsan Maura Massimino Felice Giangaspero Francesca R Buttarelli Roger J Packer Lyndsey Emery William H Yong Horacio Soto Linda M Liau Richard Everson Andrew Grossbach Tarek Shalaby Michael Grotzer Matthias A Karajannis David Zagzag Helen Wheeler Katja von Hoff Marta M Alonso Teresa Tuñon Ulrich Schüller Karel Zitterbart Jaroslav Sterba Jennifer A Chan Miguel Guzman Samer K Elbabaa Howard Colman Girish Dhall Paul G Fisher Maryam Fouladi Amar Gajjar Stewart Goldman Eugene Hwang Marcel Kool Harshad Ladha Elizabeth Vera-Bolanos Khalida Wani Frank Lieberman Tom Mikkelsen Antonio M Omuro Ian F Pollack Michael Prados H Ian Robins Riccardo Soffietti Jing Wu Phillipe Metellus Uri Tabori Ute Bartels Eric Bouffet Cynthia E Hawkins James T Rutka Peter Dirks Stefan M Pfister Thomas E Merchant Mark R Gilbert Terri S Armstrong Andrey Korshunov David W Ellison Michael D Taylor

J Clin Oncol 2016 07 6;34(21):2468-77. Epub 2016 Jun 6.

Vijay Ramaswamy, Stephen C. Mack, Alvaro Lassaletta, Betty Luu, Florence M.G. Cavalli, Uri Tabori, Ute Bartels, Eric Bouffet, Cynthia E. Hawkins, James T. Rutka, Peter Dirks, and Michael D. Taylor, The Hospital for Sick Children; Vijay Ramaswamy, Kenneth Aldape, James T. Rutka, and Michael D. Taylor, University of Toronto; Kenneth Aldape, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario; Christopher Dunham and Juliette Hukin, British Columbia Children's Hospital; Juliette Hukin, University of British Columbia, Vancouver, British Columbia; David D. Eisenstat, Dorcas Fulton, and Frank K.H. van Landeghem, University of Alberta, Edmonton; Jennifer A. Chan, University of Calgary, Calgary, Alberta; Nada Jabado and Kevin Petrecca, McGill University, Montreal, Quebec, Canada; Thomas Hielscher, Kristian W. Pajtler, David T.W. Jones, Marcel Kool, Stefan M. Pfister, and Andrey Korshunov, German Cancer Research Center; Stefan M. Pfister, University Hospital Heidelberg, Heidelberg; Marc Remke, University Hospital Düsseldorf, Düsseldorf; Martin Mynarek, Stefan Rutkowski, and Katja von Hoff, University Medical Center Hamburg-Eppendorf, Hamburg; Ulrich Schüller, Ludwig-Maximilians-Universität, Munich, Germany; Stephen C. Mack, Cleveland Clinic Foundation, Cleveland; Maryam Fouladi, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; Tong Lin, Amar Gajjar, Thomas E. Merchant, and David W. Ellison, St Jude Children's Research Hospital, Memphis; Lola B. Chambless, Vanderbilt Medical Center, Nashville, TN; Sridharan Gururangan, Roger E. McLendon, and Eric S. Lipp, Duke University, Durham; Jing Wu, University of North Carolina at Chapel Hill, Chapel Hill, NC; Mariarita Santi, Children's Hospital of Philadelphia; Lyndsey Emery, Hospital of the University of Pennsylvania, Philadelphia; Ronald L. Hamilton and Ian F. Pollack, University of Pittsburgh School of Medicine; Frank Lieberman, University of Pittsburgh Medical Cen

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962737PMC
July 2016

Future directions in glioblastoma therapy.

Authors:
Howard Colman

Am Soc Clin Oncol Educ Book 2012 :108-11

From the Department of Neurosurgery and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.108DOI Listing
April 2016

Intermittent induction of HIF-1α produces lasting effects on malignant progression independent of its continued expression.

PLoS One 2015 20;10(4):e0125125. Epub 2015 Apr 20.

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah, United States of America; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0125125PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404255PMC
April 2016

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.

Neuro Oncol 2016 Apr 8;18(4):557-64. Epub 2015 Oct 8.

University of California at San Francisco, San Francisco, California (N.B., A.P., J.P., A.M.M, M.P.); Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (H.C.); The University of Texas MD Anderson Cancer Center, Houston, Texas (J.F.D.G.); Department of Neurology, Memorial Sloan Kettering Cancer Hospital, New York, New York (A.M.O.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (L.N., P.Y.W., S.H., K.L.L.); UCLA Medical Center, Los Angeles, California (T.F.C.); Plexxikon Inc., Berkeley, California (A.M., B.L.W., K.B.N., H.H.H.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (K.L.L.); Department of Pathology, Memorial Sloan Kettering Cancer Hospital, New York, New York (J.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799682PMC
April 2016

The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation.

World Neurosurg 2016 Apr 25;88:222-236. Epub 2015 Dec 25.

Department of Neurosurgery, Clinical Neurosciences Center, Salt Lake City, Utah, USA; Huntsman Cancer Institute, Salt Lake City, Utah, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2015.12.032DOI Listing
April 2016

Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.

Neurosurg Clin N Am 2016 Apr 18;27(2):249-60. Epub 2016 Feb 18.

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, 175 N. Medical Drive East, Salt Lake City, UT 84132, USA; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nec.2015.11.002DOI Listing
April 2016

Cranial and spinal leptomeningeal dissemination in esthesioneuroblastoma: Two reports of distant central nervous system metastasis and rationale for treatment.

Surg Neurol Int 2015 25;6(Suppl 25):S628-32. Epub 2015 Nov 25.

Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2152-7806.170464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672577PMC
December 2015

Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.

Stem Cell Res Ther 2015 Oct 15;6:198. Epub 2015 Oct 15.

Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 E Dongfeng Road, Guangzhou, Guangdong, 510060, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13287-015-0174-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606508PMC
October 2015

Toward precision medicine in glioblastoma: the promise and the challenges.

Neuro Oncol 2015 Aug 1;17(8):1051-63. Epub 2015 May 1.

University of California San Francisco, San Francisco, California (M.D.P, J.J.P., A.M.M., S.M.C.); Translational Genomics Research Institute, Phoenix, Arizona (S.A.B., N.L.T., W.D.T., J.A.K., M.E.B., D.W.C., J.D.C., J.M.T.); Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (K.L.L., P.Y.W.); University of Texas Health Science Center, San Antonio, Texas (J.G.K.); Memorial Sloan-Kettering Cancer Center, New York, New York (I.K.M.); The University of Texas M.D. Anderson Cancer Center, Houston, Texas (J.F.d.G.); University of Utah Huntsman Cancer Institute, Salt Lake City, Utah (H.C.); University of California Los Angeles, Los Angeles, California (T.F.C.); Iowa Spine and Brain Institute, Waterloo, Iowa (T.C.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490873PMC
August 2015

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Authors:
Daniel J Brat Roel G W Verhaak Kenneth D Aldape W K Alfred Yung Sofie R Salama Lee A D Cooper Esther Rheinbay C Ryan Miller Mark Vitucci Olena Morozova A Gordon Robertson Houtan Noushmehr Peter W Laird Andrew D Cherniack Rehan Akbani Jason T Huse Giovanni Ciriello Laila M Poisson Jill S Barnholtz-Sloan Mitchel S Berger Cameron Brennan Rivka R Colen Howard Colman Adam E Flanders Caterina Giannini Mia Grifford Antonio Iavarone Rajan Jain Isaac Joseph Jaegil Kim Katayoon Kasaian Tom Mikkelsen Bradley A Murray Brian Patrick O'Neill Lior Pachter Donald W Parsons Carrie Sougnez Erik P Sulman Scott R Vandenberg Erwin G Van Meir Andreas von Deimling Hailei Zhang Daniel Crain Kevin Lau David Mallery Scott Morris Joseph Paulauskis Robert Penny Troy Shelton Mark Sherman Peggy Yena Aaron Black Jay Bowen Katie Dicostanzo Julie Gastier-Foster Kristen M Leraas Tara M Lichtenberg Christopher R Pierson Nilsa C Ramirez Cynthia Taylor Stephanie Weaver Lisa Wise Erik Zmuda Tanja Davidsen John A Demchok Greg Eley Martin L Ferguson Carolyn M Hutter Kenna R Mills Shaw Bradley A Ozenberger Margi Sheth Heidi J Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean Claude Zenklusen Brenda Ayala Julien Baboud Sudha Chudamani Mark A Jensen Jia Liu Todd Pihl Rohini Raman Yunhu Wan Ye Wu Adrian Ally J Todd Auman Miruna Balasundaram Saianand Balu Stephen B Baylin Rameen Beroukhim Moiz S Bootwalla Reanne Bowlby Christopher A Bristow Denise Brooks Yaron Butterfield Rebecca Carlsen Scott Carter Lynda Chin Andy Chu Eric Chuah Kristian Cibulskis Amanda Clarke Simon G Coetzee Noreen Dhalla Tim Fennell Sheila Fisher Stacey Gabriel Gad Getz Richard Gibbs Ranabir Guin Angela Hadjipanayis D Neil Hayes Toshinori Hinoue Katherine Hoadley Robert A Holt Alan P Hoyle Stuart R Jefferys Steven Jones Corbin D Jones Raju Kucherlapati Phillip H Lai Eric Lander Semin Lee Lee Lichtenstein Yussanne Ma Dennis T Maglinte Harshad S Mahadeshwar Marco A Marra Michael Mayo Shaowu Meng Matthew L Meyerson Piotr A Mieczkowski Richard A Moore Lisle E Mose Andrew J Mungall Angeliki Pantazi Michael Parfenov Peter J Park Joel S Parker Charles M Perou Alexei Protopopov Xiaojia Ren Jeffrey Roach Thaís S Sabedot Jacqueline Schein Steven E Schumacher Jonathan G Seidman Sahil Seth Hui Shen Janae V Simons Payal Sipahimalani Matthew G Soloway Xingzhi Song Huandong Sun Barbara Tabak Angela Tam Donghui Tan Jiabin Tang Nina Thiessen Timothy Triche David J Van Den Berg Umadevi Veluvolu Scot Waring Daniel J Weisenberger Matthew D Wilkerson Tina Wong Junyuan Wu Liu Xi Andrew W Xu Lixing Yang Travis I Zack Jianhua Zhang B Arman Aksoy Harindra Arachchi Chris Benz Brady Bernard Daniel Carlin Juok Cho Daniel DiCara Scott Frazer Gregory N Fuller JianJiong Gao Nils Gehlenborg David Haussler David I Heiman Lisa Iype Anders Jacobsen Zhenlin Ju Sol Katzman Hoon Kim Theo Knijnenburg Richard Bailey Kreisberg Michael S Lawrence William Lee Kalle Leinonen Pei Lin Shiyun Ling Wenbin Liu Yingchun Liu Yuexin Liu Yiling Lu Gordon Mills Sam Ng Michael S Noble Evan Paull Arvind Rao Sheila Reynolds Gordon Saksena Zack Sanborn Chris Sander Nikolaus Schultz Yasin Senbabaoglu Ronglai Shen Ilya Shmulevich Rileen Sinha Josh Stuart S Onur Sumer Yichao Sun Natalie Tasman Barry S Taylor Doug Voet Nils Weinhold John N Weinstein Da Yang Kosuke Yoshihara Siyuan Zheng Wei Zhang Lihua Zou Ty Abel Sara Sadeghi Mark L Cohen Jenny Eschbacher Eyas M Hattab Aditya Raghunathan Matthew J Schniederjan Dina Aziz Gene Barnett Wendi Barrett Darell D Bigner Lori Boice Cathy Brewer Chiara Calatozzolo Benito Campos Carlos Gilberto Carlotti Timothy A Chan Lucia Cuppini Erin Curley Stefania Cuzzubbo Karen Devine Francesco DiMeco Rebecca Duell J Bradley Elder Ashley Fehrenbach Gaetano Finocchiaro William Friedman Jordonna Fulop Johanna Gardner Beth Hermes Christel Herold-Mende Christine Jungk Ady Kendler Norman L Lehman Eric Lipp Ouida Liu Randy Mandt Mary McGraw Roger Mclendon Christopher McPherson Luciano Neder Phuong Nguyen Ardene Noss Raffaele Nunziata Quinn T Ostrom Cheryl Palmer Alessandro Perin Bianca Pollo Alexander Potapov Olga Potapova W Kimryn Rathmell Daniil Rotin Lisa Scarpace Cathy Schilero Kelly Senecal Kristen Shimmel Vsevolod Shurkhay Suzanne Sifri Rosy Singh Andrew E Sloan Kathy Smolenski Susan M Staugaitis Ruth Steele Leigh Thorne Daniela P C Tirapelli Andreas Unterberg Mahitha Vallurupalli Yun Wang Ronald Warnick Felicia Williams Yingli Wolinsky Sue Bell Mara Rosenberg Chip Stewart Franklin Huang Jonna L Grimsby Amie J Radenbaugh Jianan Zhang
June 2015

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Neuro Oncol 2015 Mar 13;17(3):440-7. Epub 2014 Aug 13.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.V.-B., M.R.G.); Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (K.A., K.W.); Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (Y.Y., J.W.); Office of Multicenter Clinical Research, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (M.J.N.-R.); Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (H.C.); Division of Hematology-Oncology, Children's Hospital Los Angeles, Los Angeles, California (G.D.); Departments of Neurology and Medicine (Medical Oncology), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (F.S.L.); Department of Neurosurgery, Assistance Publique-Hopitaux de Marseille, Aix-Marseille University, Marseille, France (P.M.); Departments of Neurology & Neurosurgery, Henry Ford Hospital, Detroit, Michigan (T.M.); Department of Neurology, Memorial-Sloan Kettering Cancer Center, New York, New York (A.O.); Department of Neurology, Stanford University & Lucile Packard Children's Hospital, Palo Alto, California (S.P.); Department of Neuro-Oncology, UCSF Helen Diller Comprehensive Cancer Center, San Francisco, California (M.P.); Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (H.I.R.); Department of Neuroscience, University San Giovanni Battista Hospital, Turin, Italy (R.S.); Department of Neurosurgery, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina (J.W.); Department of Family Health, School of Nursing, The University of Texas Health Science Center-Houston, Houston, Texas (T.S.A.); CERN Foundation, Dayton, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483095PMC
March 2015

A practical review of prognostic correlations of molecular biomarkers in glioblastoma.

Neurosurg Focus 2015 Mar;38(3):E4

Department of Neurosurgery, Clinical Neuroscience Center; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2015.1.FOCUS14755DOI Listing
March 2015

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.

Neuro Oncol 2015 Feb 19;17(2):266-73. Epub 2014 Sep 19.

Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (M.P.-P., M.D.G., V.A.L., J.F.D.G., C.A.C., M.E.L., W.K.A.Y., M.R.G.); Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas (K.R.H.); General Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (M.J.F., L.W.L.); Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas (A.M.); Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas (K.D.A); Department of Neurosurgery, Kaiser Permanente Redwood City Medical Center, Redwood City, California (V.A.L.); Department of Neurological Surgery, Ohio State University Comprehensive Cancer Center, Columbus, Ohio (V.K.P.); Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah (H.C.); Atlanta Regional Community Clinical Oncology Program, Georgia Cancer Specialists, Canton, Georgia (G.V.-.R.); Department of Neurosciences, Medical University of South Carolina Brain & Spine Tumor Program, Charleston, South Carolina (P.G.); Department of Hematology and Oncology, The University of Kansas Cancer Center, Overland Park, Kansas (M.E.S.); Department of Hematology and Oncology, Saint Francis Medical Center, Cape Girardeau, Missouri (J.D.F.); Department of Neurosurgery, University of Texas Health Science Center, Houston, Texas (S.H.H.); Department of Neurology, West Virginia University, Morgantown, West Virginia (J.G.); Department of Radiation Oncology, Keck School of Medicine, University of Southern California, U.S.C Norris Cancer Hospital, Los Angeles, California (E.L.C.); Department of Radiation Oncology, University of Louisville, James Graham Brown Cancer Center, Louisville, Kentucky (S.Y.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288521PMC
February 2015

Glioma biology and molecular markers.

Cancer Treat Res 2015 ;163:15-30

Huntsman Cancer Institute, 2000 Circle of Hope, 84112, Salt Lake City, UT,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-3-319-12048-5_2
Publisher Site
http://dx.doi.org/10.1007/978-3-319-12048-5_2DOI Listing
February 2015

A randomized trial of bevacizumab for newly diagnosed glioblastoma.

N Engl J Med 2014 Feb;370(8):699-708

From the University of Texas M.D. Anderson Cancer Center (M.R.G., T.S.A., J.S.W., P.D.B., I.W.T.-L., E.P.S., K.D.A.) and the University of Texas Health Science Center School of Nursing (T.S.A.), Houston; American College of Radiology (J.J.D., S.P., M.W.) and Thomas Jefferson University (M.W.-W.) - both in Philadelphia; the University of Chicago, Chicago (J.J.D.); Tel-Aviv Medical Center, Tel Aviv, Israel (D.T.B.); Cleveland Clinic, Cleveland (M.A.V.); the University of Utah, Salt Lake City (H.C.); Ohio State University, Columbus (A.C.); University of Wisconsin, Madison (R.J.); Mayo Clinic, Jacksonville, FL (K.A.J.); University of Virginia, Charlottesville (D.S.); Southeast Cancer Control Consortium, Winston-Salem, NC (V.W.S.); Barrow Neurologic Institute, Phoenix, AZ (D.G.B.); Emory University, Atlanta (W.J.C.); and the University of Maryland, Baltimore (M.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1308573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201043PMC
February 2014

Experimental validation of 5 in-silico predicted glioma biomarkers.

Neuro Oncol 2013 Dec 24;15(12):1625-34. Epub 2013 Oct 24.

Corresponding Author: Rheal A. Towner, PhD, Director, Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, 825 N.E. 13th Street, Oklahoma City, OK 73104 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/not124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829592PMC
December 2013

Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report.

Case Rep Oncol 2013 24;6(2):434-40. Epub 2013 Aug 24.

Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000354753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764969PMC
September 2013

Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.

Cancer Res 2013 May 14;73(10):3062-74. Epub 2013 Mar 14.

Brain Tumor Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655088PMC
May 2013

IDH1 and IDH2 mutations in gliomas.

Curr Neurol Neurosci Rep 2013 May;13(5):345

Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11910-013-0345-4
Publisher Site
http://dx.doi.org/10.1007/s11910-013-0345-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109985PMC
May 2013

ELTD1, a potential new biomarker for gliomas.

Neurosurgery 2013 Jan;72(1):77-90; discussion 91

Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0b013e318276b29dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555701PMC
January 2013

Effective elimination of cancer stem cells by a novel drug combination strategy.

Stem Cells 2013 Jan;31(1):23-34

State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.1273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538380PMC
January 2013

Medulloblastoma: molecular classifications and prognostic associations.

Oncology (Williston Park) 2012 Nov;26(11):1097, 1102

Department of Radiation Oncology, The Huntsman Cancer Hospital, USA.

View Article

Download full-text PDF

Source
November 2012

Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.

Cancer 2012 Jul 15;118(14):3599-606. Epub 2011 Nov 15.

Department of Neuro-oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26663DOI Listing
July 2012

Isolation and perivascular localization of mesenchymal stem cells from mouse brain.

Neurosurgery 2010 Sep;67(3):711-20

Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/01.NEU.0000377859.06219.78DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644957PMC
September 2010

Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation.

J Proteome Res 2010 May;9(5):2098-108

Ion Cyclotron Resonance Program, National High Magnetic Field Laboratory, Florida State University, Tallahassee, Florida 32310, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/pr900793aDOI Listing
May 2010

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.

Neuro Oncol 2010 Feb 14;12(2):116-21. Epub 2009 Dec 14.

Departments of Pathology and Radiation-Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit-0097, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nop020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940581PMC
February 2010

Glioma-associated cancer-initiating cells induce immunosuppression.

Clin Cancer Res 2010 Jan 12;16(2):461-73. Epub 2010 Jan 12.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1983DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943842PMC
January 2010

Brain tumor stem cells.

Curr Probl Cancer 2008 May-Jun;32(3):124-42

Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.currproblcancer.2008.02.004DOI Listing
July 2008

Molecular predictors in glioblastoma: toward personalized therapy.

Arch Neurol 2008 Jul;65(7):877-83

Department of Neuro-oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 431, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.65.7.877DOI Listing
July 2008

Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.

J Natl Cancer Inst 2007 Sep 11;99(18):1410-4. Epub 2007 Sep 11.

Brain Tumor Center, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djm102DOI Listing
September 2007

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.

Clin Cancer Res 2005 May;11(9):3326-34

Department of Radiation Oncology, Neuro-Oncology, and Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-1765DOI Listing
May 2005

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.

Cancer Res 2005 Mar;65(5):1678-86

Department of Neurological Surgery (Brain Tumor Research Center), University of California, School of Medicine, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-2921DOI Listing
March 2005